The
report “Pharmacovigilance
and Drug Safety Software Market by
Functionality (Adverse Event Reporting, Fully Integrated Software), Delivery
Mode (On-premise, On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech
Companies, CROs, BPOs) - Global Forecast to 2019” analyzes and studies the major market drivers,
restraints, opportunities, and challenges in North America, Europe,
Asia-Pacific, and the Rest of the world (RoW).
Browse 74 market data tables
and 57 figures spread through 210 pages
and
in-depth TOC on “Pharmacovigilance
and Drug Safety Software Market”
On the basis of functionality, the global pharmacovigilance
software market is classified into four major segments, namely, adverse event
reporting software, drug safety audits software, issue tracking software, and
fully integrated software.
The global drug safety software market is divided into two
segments on the basis of delivery mode, namely, on-premise delivery mode and
on-demand/cloud based (SaaS) delivery mode. This market is also divided into
pharma and biotech companies, contract research organizations (CROs), business process
outsourcing (BPO) firms, and other pharmacovigilance service providers on the
basis of type of end user.
The global pharmacovigilance software market is expected to grow
at a CAGR of 6.5% from 2014 to 2019. Factors such as increasing incidence rates
of adverse drug reactions (ADRs) and growing adoption of pharmacovigilance
software by organizations such as CROs and BPOs are driving the growth of the
global pharmacovigilance software market. In addition; government regulatory
bodies (such as the U.S. FDA and EMEA) have intensified safety regulations for
prior and post commercialization of drugs, which has increased pressure on the
pharmaceutical and biotechnology companies to manufacture safe drugs and
evaluate their results post sales. Thus, growing complexity related to drug
safety regulations is expected to drive the growth of the market during the
forecast period.
Get
Discount
Geography:
North America is expected to account for the
largest share of the drug safety software market, followed by Europe, in 2014.
However, Asian and Latin American countries represent high growth markets,
owing to a rise in research outsourcing by pharmaceutical giants and growing
public and private investments in pharmaceutical R&D in these emerging
nations. Some of the key players in the global pharmacovigilance software
market include ArisGlobal (U.S.), Ennov Solutions Inc. (U.S.), EXTEDO GmbH
(U.S.), Online Business Applications, Inc. (U.S.), Oracle Corporation (U.S.),
Sarjen Systems Pvt. Ltd (India), Sparta Systems, Inc. (U.S.), and United
BioSource Corporation (U.S.), among others.
ArisGlobal (U.S.), Ennov Solutions Inc. (U.S.),
EXTEDO GmbH (U.S.), Online Business Applications, Inc. (U.S.), Oracle
Corporation (U.S.), Sarjen Systems Pvt. Ltd (India), Sparta Systems, Inc.
(U.S.), and United BioSource Corporation (U.S.) are some of the key players
operating in the global drug safety software market.
No comments:
Post a Comment